SEARCH RESULTS FOR: "Tag: AXGT"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(4)
CATEGORIES
Analyst Update(3)
Buzz Stocks(1)
Intraday Option Activity(1)

8/12/2019 2:59 PM
Axovant Gene Therapies Ltd (NASDAQ:AXGT) is getting a boost from Baird today -- bucking the broad-market trend lower -- after the analyst upgraded the biotech to "outperform" from "neutral," predicti...
6/21/2019 10:34 AM
The shares of Axovant Gene Therapies Ltd (NASDAQ:AXGT) are soaring today, thanks to some upbeat analyst attention. Specifically, SVB Leerink initiated coverage of AXGT stock with an "outperform" rati...
6/12/2019 10:30 AM
Axovant Sciences Ltd (NASDAQ:AXGT) has seen its stock fall from the mid-$30 range to yesterday's close of $3.94, even after positive data for its Parkinson's treatment. However, Jefferies referred to...
3/11/2019 9:43 AM
The shares of biotechnology concern Axovant Sciences Ltd (NASDAQ:AXGT) are up 54% at $2.28 in early trading after announcing successful phase 2 trial results for its Parkinson's treatment, AXO-Lenti...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center